Pfizer Inc annual free cash flow for fiscal TTM was $9.5 billion, an increase of 4.5% from $9.1 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | $9.5B | $9.1B | $9.8B | $4.8B | $26.0B | $29.9B | $11.6B | $10.0B | $13.6B | $14.3B | $13.9B | $13.0B | $15.3B | $16.3B | $15.7B | $18.6B | $9.9B | $15.4B | $16.5B | $11.5B | $15.5B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | $2.2B | $4.5B | $4.0B | ($1.2B) | $1.8B | $5.8B | $6.1B | ($2.4B) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More PFE metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All PFE financial statements → Interactive PFE charts →
About TickerBase · Data methodology & sources